Scaffolds for bone healing: Concepts, materials and evidence

Injury

Volumn 42, Issue 6, 2011, Pages 569-573

  Lichte, P ^a   Pape, H C ^a   Pufe, T ^a   Kobbe, P ^a   Fischer, H ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Bone defect; Bone healing; Calcium Phosphate ceramic; Polymer scaffold; Rapid prototyping; Synthetic scaffold

Indexed keywords

CALCIUM PHOSPHATE; GLASS; GROWTH FACTOR; POLYMER; STEEL; TISSUE SCAFFOLD; TITANIUM;

BONE GRAFT; BONE PROSTHESIS; BONE REGENERATION; BONE REMODELING; CERAMICS; EXTRACELLULAR MATRIX; FRACTURE HEALING; IN VIVO GENE TRANSFER; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 79957849133     PISSN: 00201383     EISSN: 18790267     Source Type: Journal    
DOI: 10.1016/j.injury.2011.03.033     Document Type: Article

References (47)

1. Arinzeh TL, Peter SJ, Archambault MP, et al. Allogeneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect. J Bone Joint Surg Am 2003;85-A:1927-35. (Pubitemid 37259728)
2. Banfi A, Bianchi G, Notaro R, et al. Replicative aging and gene expression in longterm cultures of human bone marrow stromal cells. Tissue Eng 2002;8:901-10. (Pubitemid 35397236)
3. Banfi A, Muraglia A, Dozin B, et al. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: implications for their use in cell therapy. Exp Hematol 2000;28:707-15. (Pubitemid 30398528)
4. Bensaid W, Oudina K, Viateau V, et al. De novo reconstruction of functional bone by tissue engineering in themetatarsal sheep model. Tissue Eng 2005;11: 814-24. (Pubitemid 40960784)
5. Bergmann C, Lindner M, Zhang W, et al. 3D-printing of bone substitute implants using calcium phosphate and bioactive glasses. J Eur Ceram Soc 2010;30:2563-7.
6. Bostman O, Hirvensalo E, Makinen J, Rokkanen P. Foreign-body reactions to fracture fixation implants of biodegradable synthetic polymers. J Bone Joint Surg Br 1990;72:592-6. (Pubitemid 20221105)
7. Bostman O, Pihlajamaki H. Clinical biocompatibility of biodegradable orthopaedic implants for internal fixation: a review. Biomaterials 2000;21:2615-21.
8. Bostman OM, Laitinen OM, Tynninen O, Salminen ST, Pihlajamaki HK. Tissue restoration after resorption of polyglycolide and poly-laevo-lactic acid screws. J Bone Joint Surg Br 2005;87:1575-80. (Pubitemid 41723108)
9. Briggs T, Treiser MD, Holmes PF, et al. Osteogenic differentiation of human mesenchymal stem cells on poly(ethylene glycol)-variant biomaterials. J Biomed Mater Res A 2009;91:975-84.
10. Bruder SP, Kurth AA, Shea M, et al. Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. J Orthop Res 1998;16:155-62. (Pubitemid 28249153)
11. Cameron HU. Tricalcium phosphate as a bone graft substitute. Contemp Orthop 1992;25:506-8.
12. Chapman MW, Bucholz R, Cornell C. Treatment of acute fractures with a collagen-calcium phosphate graft material. A randomized clinical trial. J Bone Joint Surg Am 1997;79:495-502. (Pubitemid 27376919)
13. Connolly JF, Guse R, Tiedeman J, Dehne R. Autologous marrow injection as a substitute for operative grafting of tibial nonunions. Clin Orthop Relat Res 1991:259-70.
14. Dallari D, Savarino L, Stagni C, et al. Enhanced tibial osteotomy healing with use of bone grafts supplemented with platelet gel or platelet gel and bone marrow stromal cells. J Bone Joint Surg Am 2007;89:2413-20. (Pubitemid 350086330)
15. Datta N, Holtorf HL, Sikavitsas VI, Jansen JA, Mikos AG. Effect of bone extracellular matrix synthesized in vitro on the osteoblastic differentiation of marrow stromal cells. Biomaterials 2005;26:971-7. (Pubitemid 39208984)
16. Dawson JI, Wahl DA, Lanham SA, et al. Development of specific collagen scaffolds to support the osteogenic and chondrogenic differentiation of human bone marrow stromal cells. Biomaterials 2008;29:3105-16.
17. Dupont KM, Sharma K, Stevens HY, et al. Human stem cell delivery for treatment of large segmental bone defects. Proc Natl Acad Sci USA 2010;107:3305-10.
18. El Ghannam A. Bone reconstruction: from bioceramics to tissue engineering. Expert Rev Med Devices 2005;2:87-101.
19. Fang J, Zhu YY, Smiley E, et al. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc Natl Acad Sci USA 1996;93:5753-8. (Pubitemid 26190752)
20. Geiger F, Bertram H, Berger I, et al. Vascular endothelial growth factor gene-activated matrix (VEGF165-GAM) enhances osteogenesis and angiogenesis in large segmental bone defects. J Bone Miner Res 2005;20:2028-35. (Pubitemid 41532788)
21. Giannoudis PV, Dinopoulos H, Tsiridis E. Bone substitutes: an update. Injury 2005;36(Suppl. 3):S20-7.
22. Hernigou P, Poignard A, Beaujean F, Rouard H. Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. J Bone Joint Surg Am 2005;87:1430-7. (Pubitemid 40917741)
23. Janning C, Willbold E, Vogt C, et al. Magnesium hydroxide temporarily enhancing osteoblast activity and decreasing the osteoclast number in peri-implant bone remodelling. Acta Biomater 2010;6:1861-8.
24. Jones JR, Ehrenfried LM, Hench LL. Optimising bioactive glass scaffolds for bone tissue engineering. Biomaterials 2006;27:964-73. (Pubitemid 41566688)
25. Kanakaris NK, Lasanianos N, Calori GM, et al. Application of bone morphogenetic proteins to femoral non-unions: a 4-year multicentre experience. Injury 2009;40(Suppl. 3):S54-61.
26. Kuhne JH, Bartl R, Frisch B, et al. Bone formation in coralline hydroxyapatite. Effects of pore size studied in rabbits. Acta Orthop Scand 1994;65:246-52.
27. Lane JM, Tomin E, Bostrom MP. Biosynthetic bone grafting. Clin Orthop Relat Res 1999:S107-17.
28. Laschke MW, Strohe A, Menger MD, Alini M, Eglin D. In vitro and in vivo evaluation of a novel nanosize hydroxyapatite particles/poly(ester-urethane) composite scaffold for bone tissue engineering. Acta Biomater 2010;6:2020-7.
29. Lindner M, Hoeges S, Meiners W, et al. Manufacturing of individual biodegradable bone substitute implants using selective laser melting technique. J Biomed Mater Res A 2011. in press.
30. Liu Y, Lu Y, Tian X, et al. Segmental bone regeneration using an rhBMP-2-loaded gelatin/nanohydroxyapatite/fibrin scaffold in a rabbit model. Biomaterials 2009;30:6276-85.
31. Marcacci M, Kon E, Moukhachev V, et al. Stem cells associated with macroporous bioceramics for long bone repair: 6- to 7-year outcome of a pilot clinical study. Tissue Eng 2007;13:947-55. (Pubitemid 46870419)
32. Marsell R, Einhorn TA. The role of endogenous bone morphogenetic proteins in normal skeletal repair. Injury 2009;40(Suppl. 3):S4-7.
33. McAndrew MP, Gorman PW, Lange TA. Tricalcium phosphate as a bone graft substitute in trauma: preliminary report. J Orthop Trauma 1988;2:333-9.
34. Neen D, Noyes D, Shaw M, et al. Healos and bone marrow aspirate used for lumbar spine fusion: a case controlled study comparing healos with autograft. Spine (Phila Pa 1976) 2006;31:E636-40.
35. Ooboshi H, Sadoshima S, Yao H, et al. Inhibition of ischemia-induced dopamine release by omega-conotoxin, a calcium channel blocker, in the striatum of spontaneously hypertensive rats: in vivo brain dialysis study. J Neurochem 1992;58:298-303.
36. Peter SJ, Miller MJ, Yasko AW, Yaszemski MJ, Mikos AG. Polymer concepts in tissue engineering. J Biomed Mater Res 1998;43:422-7. (Pubitemid 28544101)
37. Pham QP, Kasper FK, Scott BL, et al. The influence of an in vitro generated bone-like extracellular matrix on osteoblastic gene expression of marrow stromal cells. Biomaterials 2008;29:2729-39.
38. Porter JR, Ruckh TT, Popat KC. Bone tissue engineering: a review in bone biomimetics and drug delivery strategies. Biotechnol Prog 2009;25:1539-60.
39. Scaglione S, Lazzarini E, Ilengo C, Quarto R:. A composite material model for improved bone formation. J Tissue Eng Regen Med 2010.
40. Schmid U, Thielemann F, Weise K, Ochs BG. A novel therapeutic approach to bone replacement: vitalisation of industrial processed allogenic bone graft with autologous bone marrow. Z Orthop Unfall 2007;145:221-9.
41. Srouji S, Ben David D, Lotan R, et al. Slow-release hrBMP-2 embedded within electrospun scaffolds for regeneration of bone defect: in vitro and in vivo evaluation. Tissue Eng Part A; 2010.
42. Terella A, Mariner P, Brown N, Anseth K, Streubel SO. Repair of a calvarial defect with biofactor and stem cell-embedded polyethylene glycol scaffold. Arch Facial Plast Surg 2010;12:166-71.
43. ThibaultMM, Hoemann CD, Buschmann MD. Fibronectin, vitronectin, and collagen I induce chemotaxis and haptotaxis of human and rabbitmesenchymal stem cells in a standardized transmembrane assay. Stem Cells Dev 2007;16:489-502. (Pubitemid 47016234)
44. Thibault RA, Scott BL, Mikos AG, Kasper FK. Osteogenic differentiation of mesenchymal stem cells on pregenerated extracellular matrix scaffolds in the absence of osteogenic cell culture supplements. Tissue Eng Part A 2010;16:431-40.
45. Tour G, Wendel M, Tcacencu I. Cell-derived matrix enhances osteogenic properties of hydroxyapatite. Tissue Eng Part A; 2010.
46. Witte F, Ulrich H, Palm C, Willbold E:. Biodegradable magnesium scaffolds. Part II. Peri-implant bone remodeling. J Biomed Mater Res A 2007;81:757-65. (Pubitemid 46786908)
47. Xu Q, Lu H, Zhang J, et al. Tissue engineering scaffold material of porous nanohydroxyapatite/polyamide 66. Int J Nanomed 2010;5:331-5.